Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

This publication has 10 references indexed in Scilit:

• American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
  Journal of the American College of Cardiology, 2003
• Comparison of successful and failed alcohol septal ablations for obstructive hypertrophic cardiomyopathy
  The American Journal of Cardiology, 2003
• Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
  New England Journal of Medicine, 2003
• Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
  European Heart Journal, 2002
• Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions
  Circulation, 2002
• Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
  Journal of the American College of Cardiology, 2001
• Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
  Journal of the American College of Cardiology, 2001
• Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy
  Journal of the American College of Cardiology, 2001
• Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
  Heart, 2000
• Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy
  The Lancet, 2000